Search Results for: First Clinical Milestone Achieved in
Articles
Evelo Biosciences Announces Positive Phase 2 Clinical Data With EDP1815 in Psoriasis September 28, 2021
Evelo Biosciences, Inc. recently announced positive data from its Phase 2 study evaluating EDP1815 versus placebo for the treatment of mild and moderate psoriasis. A statistically significant reduction in the….
XOMA Earns $2-Million Milestone From Takeda November 18, 2020
XOMA Corporation recently announced it has earned a $2-million milestone payment from Takeda Pharmaceutical Company Limited as the first patient has been dosed….
PDC*line Pharma Announces First Patient Dosed With its Therapeutic Cancer Vaccine March 5, 2020
PDC*line Pharma recently announced the first patient was dosed with its innovative medicinal product candidate PDC*lung01 in a Phase 1/2 trial in….
Arecor Achieves Second License Milestone Payment From Global Pharmaceutical Partner February 26, 2020
Arecor Ltd recently announced it has achieved an important second, contractual milestone with one of its pharmaceutical partners….
Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial March 7, 2019
Ritter Pharmaceuticals, Inc. recently announced it has completed, ahead of schedule, enrollment in its first pivotal Phase 3 clinical trial...STRATA Skin Sciences Announces Completion of a Clinical Study October 8, 2018
STRATA Skin Sciences recently announced the completion of a multi-center clinical study investigating the efficiency and efficacy of its FDA...Nabriva Therapeutics Announces Positive Topline Results From Pivotal Phase 3 Clinical Trial of Oral Lefamulin June 6, 2018
Nabriva Therapeutics plc recently announced positive topline results from its Lefamulin Evaluation Against Pneumonia (LEAP 2) clinical trial, the second of two global, pivotal Phase 3 clinical trials of lefamulin. LEAP 2 evaluated the safety and efficacy of 5 days of oral lefamulin compared to 7 days of oral moxifloxacin in adult patients with moderate community-acquired bacterial pneumonia (CABP).
Aduro Announces Development Milestone Achieved Under Merck Collaboration March 16, 2018
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with Merck…
Aduro Announces Development Milestone Achieved Under Merck Collaboration March 5, 2018
Aduro Biotech, Inc. recently announced that the company earned a $3-million development milestone payment under its worldwide licensing agreement with...Lead Pharma Achieves Third Milestone in Sanofi Collaboration November 27, 2017
Lead Pharma recently announced it has achieved a third milestone under its research collaboration with Sanofi, triggering an undisclosed milestone...Onxeo Announces Positive Preclinical Results July 7, 2017
Onxeo S.A. recently announced positive preclinical proof-of-concept results confirming the activity via systemic (intravenous, IV) administration of AsiDNA, the company’s...Financial Milestone Achieved in Catalyst’s Subcutaneous Factor IX Program July 7, 2017
Catalyst Biosciences, Inc. recently announced it has achieved a financial milestone under its collaboration with ISU Abxis. In June 2017,...Key Milestone Reached in Catalyst’s Subcutaneous Factor IX Program April 17, 2017
Catalyst Biosciences, Inc. recently announced it has achieved a key milestone under its collaboration with ISU Abxis to advance the...Tetraphase Pharmaceuticals Completes Enrollment of IGNITE4 Phase III Clinical Trial April 10, 2017
Tetraphase Pharmaceuticals, Inc. recently announced completion of enrollment in IGNITE4, its ongoing Phase III clinical trial evaluating the efficacy and...CLINICAL TRIALS - It’s Time to Revamp the Unsexy Plumbing of Clinical Trials April 3, 2017
Craig Morgan says as clinical trials continue to evolve, drug companies will no longer be able to rely on existing, tried-and-tested manual methods or point solutions for success. And technology integration in the eClinical stack is not sufficient to bring about the step change in productivity that has to happen.
EXECUTIVE INTERVIEW - Vetter: Establishing a Successful Clinical Fill & Finish Manufacturing Site for Biologics April 3, 2017
Dr. Susanne Resatz, President of Vetter Development Services USA, Inc., discusses the many benefits to small biotech companies in utilizing the services of a full-service CDMO, and what advanced services the Chicago-based facility offers its growing customer base.
Calithera to Receive $12-Million Milestone Payment From Incyte April 3, 2017
Calithera Biosciences, Inc. recently announced it has achieved pharmacokinetic and pharmacodynamic goals for CB-1158 which, under its agreement with Incyte...Ablynx Achieves First Milestone From Novo Nordisk December 5, 2016
Ablynx recently announced it has achieved an initial discovery milestone with a multi-specific Nanobody construct as part of its collaboration...Concert Pharmaceuticals Achieves $2-Million Milestone From Avanir Pharmaceuticals November 20, 2015
Concert Pharmaceuticals, Inc. recently announced it has achieved a $2-million milestone under its development and license agreement with Avanir Pharmaceuticals,...Ophthotech Corporation Achieves $50-Million Milestone September 14, 2014
Ophthotech Corporation (OPHT) recently announced it has achieved a $50- million enrollment milestone payment from Novartis Pharma AG as part...
